C F Lippa
Overview
Explore the profile of C F Lippa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
1687
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ozudogru S, Lippa C
Am J Alzheimers Dis Other Demen
. 2012 Jul;
27(5):296-300.
PMID: 22815077
At this time there are no effective methods to alter the disease course in Alzheimer's disease. All FDA approved interventions are for symptomatic relief only. However, it is an exciting...
2.
Irwin D, Revuelta G, Lippa C
J Neurol Sci
. 2008 Nov;
277(1-2):164-6.
PMID: 19013587
Dystonia associated with neurodegenerative disease has minimal effective treatment options and can be devastating to a patient's ability to perform tasks of daily living. We present a case of a...
3.
Irwin D, Lippa C, Rosso A
J Neurol Sci
. 2008 Oct;
276(1-2):9-13.
PMID: 18848708
Mutations in the gene progranulin (PGRN) were recently identified as the cause of some forms of frontotemporal dementia with ubiquitin-positive intraneuronal inclusion pathology (FTLD-U). The DNA-binding protein, TDP-43, was determined...
4.
Lippa C, Duda J, Grossman M, Hurtig H, Aarsland D, Boeve B, et al.
Neurology
. 2007 Mar;
68(11):812-9.
PMID: 17353469
For more than a decade, researchers have refined criteria for the diagnosis of dementia with Lewy bodies (DLB) and at the same time have recognized that cognitive impairment and dementia...
5.
Dickson D, Bergeron C, Chin S, Duyckaerts C, Horoupian D, Ikeda K, et al.
J Neuropathol Exp Neurol
. 2002 Nov;
61(11):935-46.
PMID: 12430710
A working group supported by the Office of Rare Diseases of the National Institutes of Health formulated neuropathologic criteria for corticobasal degeneration (CBD) that were subsequently validated by an independent...
6.
Carter J, Lippa C
Curr Mol Med
. 2002 Mar;
1(6):733-7.
PMID: 11899259
Alzheimer's disease (AD) is a common neurodegenerative disease that affects cognitive function in the elderly. Large extracellular beta-amyloid (Abeta) plaques and tau-containing intraneuronal neurofibrillary tangles characterize AD from a histopathologic...
7.
Lippa C, Schmidt M, Lee V, Trojanowski J
Arch Neurol
. 2001 Nov;
58(11):1817-20.
PMID: 11708989
Background: Alpha-synuclein is a major component of Lewy bodies (LBs) in Parkinson disease and dementia with LBs and of glial cytoplasmic inclusions in multiple system atrophy. However, epitope mapping for...
8.
Shafiq M, Nee L, Grafman J, Tresser N, Lee V, Trojanowski J, et al.
Neurology
. 2001 Jun;
56(11 Suppl 4):S31-4.
PMID: 11402148
The authors describe a 49-year-old woman (R.K.) who presented with one year of progressive frontal lobe dysfunction, including signs of expressive aphasia. Signs of parkinsonism were absent until late in...
9.
Nee L, Lippa C
Am J Alzheimers Dis Other Demen
. 2001 Apr;
16(2):83-4.
PMID: 11302075
This study was undertaken to evaluate smell tests as a clinical marker for identifying mutation carrier status and determining the clinical diagnosis of presenilin-1 Alzheimer's disease (AD) in family members...
10.
Shoji M, Iwakami N, Takeuchi S, Waragai M, Suzuki M, Kanazawa I, et al.
Brain Res Mol Brain Res
. 2001 Jan;
85(1-2):221-33.
PMID: 11146125
c-Jun has been implicated in the pathogenesis of Alzheimer's disease (AD), but the upstream cascade leading to c-Jun activation in AD is not known. Activation of c-Jun N-terminal kinase (JNK)...